M&A Corner
How Amazon’s entry into the pharmacy business could improve patient care07 Jul 2018
Amazon’s plan to buy online pharmacy PillPack, widely seen as a move that will disrupt the pharmacy business, could have... Continue Reading
|
Amazon’s PillPack deal puts a bull’s-eye on drug distributors and pharmacies07 Jul 2018
Amazon.com Inc.’s deal to buy online pharmacy PillPack put a dent in the stock prices of major drug distributors and... Continue Reading
|
Amazon’s acquisition of online pharmacy PillPack spooks retail drugstores07 Jul 2018
After months of speculation about when Amazon would officially enter the drug distribution market, the online retail giant offered a... Continue Reading
|
Amazon buys PillPack, an online pharmacy, for just under $1B02 Jul 2018
A week after appointing a CEO for its healthcare joint venture with Berkshire Hathaway and JPMorgan, Amazon today announced an... Continue Reading
|
Thermo Fisher Scientific Signs Agreement to Acquire Gatan from Roper Technologies02 Jul 2018
Thermo Fisher Scientific Inc., the world leader in serving science, and Roper Technologies, Inc., a leading diversified technology company, today... Continue Reading
|
Sanofi, Advent finally shake hands on $2.2B European generics sale02 Jul 2018
It’s official: Sanofi is finally ready to unload its European generics business. More than two months after disclosing that they... Continue Reading
|
Repligen Merging with Spectrum Labs in $359M Deal02 Jul 2018
Repligen said today it plans to merge with privately-held Spectrum Laboratories, in an approximately $359 million deal that Repligen said... Continue Reading
|
Stryker to fight surgical fire hazards with SafeAir acquisition02 Jul 2018
Stryker Corp. agreed to acquire Swiss medical device company SafeAir AG, The Daily Times reports. SafeAir designs, develops and manufactures... Continue Reading
|
Repligen Announces Agreement with Navigo Proteins for the Exclusive Co-Development of Next Generation Affinity Ligands02 Jul 2018
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, today announced an agreement with Navigo Proteins GmbH for... Continue Reading
|
Roche buys out Foundation Med in $2.4B bet on targeted cancer treatment02 Jul 2018
Dive Brief: Swiss pharma Roche will pay $2.4 billion to acquire the rest of Foundation Medicine that it doesn’t already... Continue Reading
|